# OnCo record nivopostop (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nivopostop/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nivopostop", "NCT03576417" ;
  schema:name "NIVOPOSTOP (GORTEC 2018-01)"@en ;
  schema:description "NIVOPOSTOP showed that adding the immunotherapy nivolumab to chemoradiation after surgery for high-risk head and neck cancer kept about one in ten more patients free of relapse at three years, the first improvement in post-operative treatment in two decades."@en ;
  schema:url <https://onco.cc/trials/nivopostop/> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT03576417> ;
  onco:status "positive" ;
  onco:phase "3" ;
  onco:cancers <https://onco.cc/cancers/head-and-neck/>, <https://onco.cc/cancers/hpv-negative-head-and-neck-cancer/> ;
  onco:technologies <https://onco.cc/technologies/checkpoint-inhibitor/>, <https://onco.cc/technologies/imrt-igrt/> ;
  onco:targets <https://onco.cc/targets/pd1/> ;
  onco:drugs <https://onco.cc/drugs/nivolumab/>, <https://onco.cc/drugs/cisplatin/> ;
  onco:terms <https://onco.cc/terms/chemoradiation/>, <https://onco.cc/terms/neoadjuvant-adjuvant/>, <https://onco.cc/terms/efs/> ;
  onco:trials <https://onco.cc/trials/keynote-689/> ;
  onco:people <https://onco.cc/people/jean-bourhis/> .